SAM
KLRS

Sectoral Asset Management’s Kalaris Therapeutics KLRS Stock Holding History

Sectoral Asset Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,350
Closed -$3.38M – 118
2021
Q4 		$3.38M Sell
11,350
-101
-0.9% -$46.9K 0.51% 69
2021
Q3 		$6.6M Buy
11,451
+9,931
+653% +$4.6M 0.55% 74
2021
Q2 		$690K Buy
1,520
+587
+63% +$303K 0.06% 112
2021
Q1 		$502K Buy
933
+509
+120% +$428K 0.04% 102
2020
Q4 		$375K Sell
424
-11,654
-96% -$8.97M 0.03% 95
2020
Q3 		$7.64M Buy
+12,078
New +$8.25M 0.66% 59

Other funds holding KLRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Sectoral Asset Management's KLRS Position: Q1 2022 in Review

Sectoral Asset Management sold out of Kalaris Therapeutics (KLRS) in Q1 2022, closing a stake of 11,350 shares — an estimated $3.38M sold.

Sectoral Asset Management first reported a position in KLRS in Q3 2020 and held it in 6 quarters. The position peaked at $7.64M in Q3 2020. 84 funds tracked by Wall St. Rank hold KLRS as of Q1 2022.

  • Sectoral Asset Management reported no remaining Kalaris Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Sectoral Asset Management sold 11,350 Kalaris Therapeutics shares in Q1 2022, an estimated $3.38M.
  • Sectoral Asset Management first reported a position in Kalaris Therapeutics in Q3 2020 and held it in 6 quarters.
  • Sectoral Asset Management's Kalaris Therapeutics position peaked at $7.64M in Q3 2020.
  • 84 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q1 2022.

Based on Sectoral Asset Management's 13F filing for Q1 2022, filed 10 May 2022.